We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

60 hedge funds and large institutions have $44.4M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 8

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

5% more funds holding

Funds holding: 57 → 60 (+3)

48% less capital invested

Capital invested by funds: $86.2M → $44.4M (-$41.8M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
60
Holders Change
+3
Holders Change %
+5.26%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
31
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.48M
2
State Street
State Street
Massachusetts
+$633K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$559K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$287K
5
Northern Trust
Northern Trust
Illinois
+$272K

Top Sellers

Rank Fund Capital Flow
1
Baird Financial Group
Baird Financial Group
Wisconsin
-$2.12M
2
CAM
Cormorant Asset Management
Massachusetts
-$1.75M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$420K
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$237K
5
N
Nuveen
North Carolina
-$82.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$12.4K +$515 +316 +3%
UBS Group
52
UBS Group
Switzerland
$12K +$12K +7,363 +263%
Squarepoint
53
Squarepoint
New York
$12K +$16.5K +10,140 New
EPWM
54
Essex Private Wealth Management
Massachusetts
$11.8K – – –
Citigroup
55
Citigroup
New York
$5.2K -$10.2K -6,251 -59%
Fidelity Investments
56
Fidelity Investments
Massachusetts
$3.13K +$3.73K +2,292 +642%
BAM
57
Belpointe Asset Management
Nevada
$2.95K +$4.07K +2,500 New
CUAMC
58
China Universal Asset Management Company
China
$1.82K +$2.51K +1,539 New
National Bank of Canada
59
National Bank of Canada
Quebec, Canada
$928 – – –
TIM
60
Tortoise Investment Management
New York
$2 +$3 +2 New
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
– -$51K -22,017 Closed
CWM
62
Congress Wealth Management
Massachusetts
– -$46K -20,000 Closed
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
– -$39 -16,244 Closed
SG Americas Securities
64
SG Americas Securities
New York
– -$29K -12,488 Closed
Wells Fargo
65
Wells Fargo
California
– -$3K -1,317 Closed
PA
66
Parallel Advisors
California
– -$1K -347 Closed
1 2
3

GRNA Hedge Fund Activity: Q4 2022 in Review

60 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q4 2022, worth a combined $44.4M — down 48% from $86.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GRNA positions and 6 closed out — a net gain of 3 holders — while 31 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $2.48M. The largest seller was Baird Financial Group, cutting an estimated $2.12M.

  • 60 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q4 2022, up from 57 in Q3 2022.
  • Funds reported $44.4M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q4 2022, down 48% quarter-over-quarter.
  • 9 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q4 2022 and 6 closed out, a net change of +3 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q4 2022 was BlackRock, an estimated $2.48M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q4 2022 was Baird Financial Group, an estimated $2.12M sold.

Based on aggregated 13F filings for Q4 2022.